Moving on to greener pastures.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well decided to try pot! Let’s see where you go. In at.44
Getting a little rich to buy. Would like to see it pull back a couple bucks
Which weed companies do you think you’re going to grow in 2018. I know that this one will because of the investment made by constellation group.
Wally I don’t need to be schooled by you. My point I was making is they will present information that will help investors make decisions about whether to invest are not in their product. You evidently did not comprehend my message properly
They are presenting at JP MORGAN 2018 Healthcare conf the 2nd week of January in SFO. So they must have some news to report or guidance
But they are getting no stores in NYC
Good luck to all I sold back at 3.25 and glad I got out with .50 profit. Will watch but it going to be a long road unless they sign up a major sales and marking partner.
I hope they find one shortly.
They are playing games keeping share price in the gutter. masa Son does not have a plan
Had to sell Sprint to take the loss against some gains on other holdings. Masa Son is crazy Sprint in big trouble.
Nice run in 2017. Does anybody think Jamie can get another 20% increase in PPS now that the tax bill has been signed by Trump.
Yep. Don’t know why other then too many penny chasers on IHub when you have big dollars like this stock.
Surprised nobody is following this great company. The 2017 chart is amazing and now another announced split for shareholders of record on 1/3/2018.
What is the up side of the stock?
Martin glad to know that information. Today I had lunch with Rick H in KC. He has been on Afrezza for 30 months and loves it. Low A1C and a great MannKind Investor. He doe not post here but is on ST posting.
His doctor has several patients on it now and I know another doctor in KC with patients. It happening and 2018 hopefully will be a great year for all of MannKind.
I know you wrote a book what is that title.
Bingo you get the prize. I don’t expect much different until after the 1st of Jan. Perhaps longer. No real catalyst unless script numbers go wild.
Earliest I see that is end of Q1 2017
These are only my high dollar shares.
I can offset some gains from some other stock and then rebuy perhaps mid to late January.
Might as well do it to get some cash elsewhere, there are some nice gains to harvest
What is the risk to sell shares today at $1.92? I have too many shares above $4.00 Sell and take the loss to wait 31 days for the wash rule.
I do believe that we will see something significant occur in the 1st or 2nd quarter of 2017. What will it be? Don’t know but somebody will take a bite of the Rite Aid apple.
Next time they sell shares it will be to an international partner for about 15% to 20% of the company at $20.00 per share. Then what happens to the share price?
Did Kresa buy at $6.00 per share because he was a chump? Or did he do it as he knows what is ahead. Why would he bought shares at $6.00.
Nobody knows but Kent Kresa and Mike Castagna.
Are they not allowed to take pay for their work or job?
Over the weekend I saw the TV ad 3 times in the St. Louis market.
How is management getting rich?
Perhaps Management will buy some some shares down low between now and the end of the year.
Or perhaps
They can’t buy knowing what is going to happen SHORTLY.
What information do you know that is going to cause it to go up in the next couple weeks
They didn’t sell 61 million shares at $6.00 per shares to fail. That is a pretty confident move for the undisclosed parties who purchased the shares.
We know that Chairman Kresa felt good about buy his $1,000,000 of new shares. The other parties who know who they are but I appreciate the confidence to buy at $6.00 and then see that they knew they proceeds went to equity in the company vs shares that churned on the street that create no benefit to the capital structure of the company.
CTO filed ahead of the vote is very interesting to me. Perhaps its a restatement of the 2014 CTO or perhaps it’s tied to the vote of the new additional shares.
Mannkind board is not looking to sell the company especially for Cheap. They would like to have new shares available for a BUY IN by a potential international partner who would provide equity to the company.
Hypothetically say that the new partner purchased a negotiated 15% or 20% interest in MannKind at $20.00 per share where would share price be that next trading day.
Diabetes is a pandemic problem worldwide. Afrezza work and the Board under Kresa with the Management team led by Mike Castagna is executing Al Mann’s plan. That plan was not to sell the company off but to see it thrive. Eventually the company will be sold but not until Afrezza becomes the Gold Standard for treatment for Diabetics worldwide just like Al’s company that sold the Insulin pump to Medtronic’s.
User’s are dumping the pump for Afrezza. Now that is just ironic.
PPS from today until 12/31 not much change or movement. UNLESS there is some type of Binary event to create the PERFECT STORM.
STAY TUNED!
You are correct. Right now you have end of years tax selling so I don’t see us climbing much until mid January 2018 or early February with 4th quarter earnings.
Mazor really over achieved this year and the PPS got heated. Hitting $65.00 was fun. Now if one had the mind set to sell at $65.00.
I actually thought about it offsetting some loses in some other equities. My view has always a buy and hold but if you are a swing trader this is a great equity to ride the up’s and downs as there will be some every quarter. Look back over the last 12 months and you can chart them out.
The question of the insider trading allegations should not concern you if you have confidence in the product, the board of director and the partnership with Medtronic
The board would have fired Ori Hadomi immediately if there was any wrong doing by anybody involved with Mazor.
That is a great take on what is about to happen with MannKind.
I have been tracking the viral and social media side of the company for more than 24 months and the trend is up. I look at Twitter statistics on my name regarding articles about MannKind. Clicks to view used to be very small a couple hundred now they are a couple thousand.
Good things are building with advertising. It’s not a sprint but it’s a marathon.
Mazor Robotics Confirms CEO Was Questioned as Part of Israel Insider Trading Investigation
BY MT NEWSWIRES — 12/05/2017
10:56 AM EST, 12/05/2017 (MT Newswires) -- Mazor Robotics (MZOR) confirmed Tuesday that its CEO, Ori Hadomi, has been questioned by the Israeli Securities Authority in connection with an investigation of insider trading related to third parties.
The company said in a regulatory filing that both a search of Mazor's offices and Hadomi's interrogation were conducted on the same date in May, noting that, to its knowledge, since then Hadomi was not called for any further questioning.
"Mazor and Mr. Hadomi intend to continue to cooperate with the ISA in the future, to the extent required. Mr. Hadomi continues to operate in his capacity as Mazor's Chief Executive Officer," Mazor said. "The board of directors of Mazor have expressed their full support and confidence in Mr. Hadomi and in his continuous leadership of Mazor and its development."
Price: 55.10, Change: -0.63, Percent Change: -1.14
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
© 1999-2017 Midnight Trader, Inc. All rights reserved.
Based on what will he turn the share price around on? There is nothing in the short term to move the PPS up.
Even worse as the share price drops down to .15 or lower before the end of 2017. No timetable for FDA approval this company will be bankrupt SHORTLY.
TRXC has one advantage that a Titan does not. That they have FDA approval on 20+ types of procedures.
TRXC will make it with a good partner but Titan will go bankrupt since they are years away from any type of FDA approval.
FDA approval means a lot to any company. It’s hard to jump pass all the hurdles to get there. That is where the real value is to partner in the field as they have something to market.
Then they better find a legitimate partner as they can’t do it with a tiny in-house sales and marketing team.
If they don’t make a partnership with a known company they will run out of cash and be ripe for Bankruptcy at which time a known company will buy the assets on the cheap. They would be better to send a company like J & J or ISRG a 15% to 20% interesting much like what Mazor has done with Medtronic.
A partner will all the company to focus on making product and R & D. Somebody else needs to make the sales.
You’re speaking a lot of baloney. I hold the stock and have no issue with it look at the increase its head over the past 12 months.
Noise today regarding Mazor. The claim is that last May or June raid by Israeli regulators that Ori Hadomi had his cell phone taken along what his computer. I call this information FUD unless the Israeli regulators issue a statement regarding what their findings were.
If the Mazor Board of Directors felt the need to remove CEO Ori Hadomi they would have done so by now. The Board of Directors of Mazor would not play around and keep a liability on their payroll as CEO / President.
My view is that Ori Hadomi is doing a great job and his communications have been on target. It does not seem plausible that he leaked any information about their partnership with Medtronic that influenced buyers or sellers of Mazor shares.
If he is found guilty then the board will act within their fiduciary duties and fire him from the company.
Anytime a stock goes from $20.50 this time last year to a high of $65.00 last month one wonders who what and why is driving the rise and if there is information being leaked.
Hopefully we find there is nothing but FUD here.
I am long on Mazor.
Problem Masa Son does not care about share price when he owns 80%
The risk he has is that nobody is going to loan sprint capital so he will have to self fund and eventually run out of money. I need to be at 8.5 to exit. Or I just sell for a loss today which is why Masa has depressed the PPS vs it rising when he is trying to acquire his up to 85%.
It is my understanding he can’t own more than 85% of a Communications company.
I have to agree with you. No FDA approval, cash or ability to market without either of the two above items.
I agree it has nothing to do with end of year tax selling. There is not a clear future and this stock most likely will be at .001 by early 2018.
I call .15 by Christmas Eve. Sorry they need to get FDA approval and they don’t have the finances to get to the goal line.
Based on what fact? Or facts.
What
Where
And
When.
Give us the three top bidders for the company.
The first sale was not a hard sell of product. It was a gift to a supportive hospital who in exchange for assistance got a gift from TransEnterix.
They can’t monetize the product without a big partner. They will run out of cash. The likely suspects can wait them out and buy the product for nothing or or make a viable partnership with their partner buying about 15% or 20% of the company and turn over all sales & marketing to their partner while they focus on building and product development.
Amen well stated. Makes no sense without a partner. Product will not sell
That is a very distinct possibility
.15 on Christmas Eve. The boat is taking on a lot of water in lisping to one side. Without FDA approval Titan is not have a very good future.
They have taken way too long to get their surgical robotic tools to market.
It’s hard to be positive when they just don’t seem to have a plan to cross the goal line.